peptide yy
Peptideexperimental
Peptide YY (PYY), also known as peptide tyrosine tyrosine, is a peptide that in humans is encoded by the PYY gene. Peptide YY is a short peptide released from cells in the ileum and colon in response to feeding. In the blood, gut, and other elements of periphery, PYY acts to reduce appetite; similarly, when injected directly into the central nervous system, PYY is also anorexigenic, i.e., it reduces appetite. — Wikipedia
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2004 (NCT00259246)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPeptide YY ↗
- NCATST2670C12I5 ↗
Also known as
- peptide yy
- peptide yy
- pyy1-36
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02493959 | Early Phase 1 (Phase 1) | May 1, 2014 | University of Copenhagen |
| NCT00331175 | Phase 1 | Jul 1, 2006 | Pfizer |
| NCT00259233 | N/A | Mar 1, 2005 | Nordic Bioscience, University of Copenhagen |
| NCT00259246 | N/A | Jun 1, 2004 | Nordic Bioscience, University of Copenhagen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Copenhagen | Academic/Hospital | 3 | 3 | 2 | 2004 |
| Nordic Bioscience | For profit | 2 | 0 | 1 | 2004 |
| Pfizer | For profit | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1